Clinical Trials Directory

Trials / Completed

CompletedNCT01209962

A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University of Michigan Rogel Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health factors. The goals of therapy are to reduce or eliminate the cancer cells, but without serious damage to normal cells. Investigators at The University of Michigan are conducting a research project, to see if treatment effects on an individual patient's cancer cells can be detected early by new imaging tests in patients with resectable pancreatic cancer undergoing neoadjuvant chemoradiotherapy.

Detailed description

Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health factors. The goals of therapy are to reduce or eliminate the cancer cells, but without serious damage to normal cells.Each patient is unique in terms of the cancer type and location and its sensitivity to treatments. Investigators at The University of Michigan are conducting a research project to see if treatment effects on an individual patient's cancer cells can be detected early by new imaging tests in patients with resectable pancreatic cancer undergoing neoadjuvant chemoradiotherapy. Each patient is unique in terms of the cancer type and location and its sensitivity to treatments.

Conditions

Timeline

Start date
2008-05-01
Primary completion
2015-05-26
Completion
2015-05-26
First posted
2010-09-27
Last updated
2017-07-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01209962. Inclusion in this directory is not an endorsement.